Sale!

WHRN Gene Deafness Autosomal Recessive Type 31 Genetic Test

Original price was: $700.Current price is: $500.

-29%

The WHRN Gene Deafness Autosomal Recessive Type 31 NGS Genetic DNA Test is a comprehensive genetic analysis that identifies mutations in the WHRN gene responsible for autosomal recessive nonsyndromic hearing loss. This advanced next-generation sequencing test provides crucial information for individuals with hereditary hearing impairment, enabling accurate diagnosis and informed family planning decisions. The test detects specific genetic variants that affect inner ear function and auditory nerve development. Results are typically available within 3-4 weeks from blood or DNA samples. At only $500 USD, this test offers affordable access to cutting-edge genetic diagnostics for hearing disorders. Early detection through this test can guide appropriate interventions and management strategies for affected individuals and their families.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

WHRN Gene Deafness Autosomal Recessive Type 31 NGS Genetic DNA Test

Comprehensive Genetic Testing for Hereditary Hearing Loss

The WHRN Gene Deafness Autosomal Recessive Type 31 NGS Genetic DNA Test represents a breakthrough in molecular diagnostics for hereditary hearing disorders. This sophisticated genetic analysis utilizes next-generation sequencing technology to identify mutations in the WHRN (Whirlin) gene, which plays a critical role in the development and maintenance of hair cells in the inner ear. These specialized sensory cells are essential for converting sound vibrations into electrical signals that the brain interprets as sound.

What This Test Measures and Detects

This advanced genetic test specifically targets the WHRN gene located on chromosome 9q32, which encodes the whirlin protein crucial for stereocilia organization in cochlear hair cells. The test identifies:

  • Pathogenic variants in the WHRN gene associated with autosomal recessive nonsyndromic hearing loss
  • Point mutations, insertions, deletions, and splice site variants
  • Genetic markers for DFNB31, a specific form of congenital hearing impairment
  • Carrier status for individuals with family history of hearing loss
  • Compound heterozygous mutations that may cause hearing disorders

Who Should Consider This Genetic Test

This test is particularly recommended for individuals experiencing:

  • Congenital or early-onset hearing loss without other syndromic features
  • Progressive sensorineural hearing impairment starting in childhood
  • Family history of autosomal recessive hearing disorders
  • Unexplained bilateral hearing loss in infants and children
  • Consanguineous parents concerned about genetic hearing conditions
  • Individuals planning pregnancy with family history of hearing impairment

Clinical Benefits of WHRN Gene Testing

Undergoing this genetic analysis provides numerous advantages for patients and families:

  • Accurate Diagnosis: Confirms genetic basis of hearing loss, eliminating diagnostic uncertainty
  • Family Planning Guidance: Enables informed reproductive decisions and genetic counseling
  • Early Intervention: Facilitates timely implementation of hearing aids, cochlear implants, or communication strategies
  • Prognostic Information: Helps predict progression and severity of hearing impairment
  • Differential Diagnosis: Distinguishes between various genetic forms of hearing loss
  • Research Contribution: Advances understanding of genetic hearing disorders

Understanding Your Test Results

Your genetic test report will provide comprehensive information about your WHRN gene status:

  • Normal Result: No pathogenic variants detected in the WHRN gene
  • Carrier Status: One mutated copy identified – typically asymptomatic but important for family planning
  • Affected Status: Two mutated copies confirmed – indicates genetic hearing loss
  • Variant of Uncertain Significance: Genetic change identified with unknown clinical impact

All results are accompanied by detailed interpretation from our certified genetic counselors, who provide personalized guidance based on your specific genetic findings and family history.

Test Pricing and Availability

Test Name Discount Price Regular Price
WHRN Gene Deafness Autosomal Recessive Type 31 NGS Genetic DNA Test $500 USD $700 USD

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, San Francisco, and many more. Our network of certified genetic testing facilities ensures accessible, reliable service regardless of your location.

Take Control of Your Genetic Health Today

Don’t let uncertainty about hereditary hearing conditions affect your quality of life. Our WHRN Gene Deafness Autosomal Recessive Type 31 NGS Genetic DNA Test provides the clarity you need for informed healthcare decisions. With results available in just 3-4 weeks and multiple sample collection options including blood, extracted DNA, or blood spots on FTA cards, getting tested has never been more convenient.

Ready to schedule your genetic test? Contact our genetic specialists today at +1(267) 388-9828 or book your appointment online. Take the first step toward understanding your genetic hearing health with confidence and precision.